Botulinum Toxin Type A
CAS 93384-43-1 4 FDA-DMF suppliersBiologic
Overview
Botulinum Toxin Type A, a neurotoxic protein produced by the bacterium Clostridium botulinum, is used for medical and cosmetic purposes to cause muscle relaxation by blocking acetylcholine release at the neuromuscular junction. It is commonly utilized in conditions like chronic migraines, hyperhidrosis, and various forms of muscle spasticity.
Therapeutic areas
NeurologyDermatologyOphthalmology
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.